LinderBCassorlaF. Short sature: Etiology, diagnosis and treatmentJAMA1988; 260: 3171–5.
2.
HintzRL. Disorders of growth. In: BraunwaldEIsselbacherKJPetersdorfRGWilsonJDMartinJBFauciAS, eds. Harrison's principles of internal medicine. 11th ed. New York: McGraw-Hill, 1987: 1718–22.
3.
PintorCCordaRPuggioniRClonidine accelerates growth in children with impaired growth hormone secretion. Lancet1985; 1: 1482–5.
4.
RallisonML. Growth disorders in infants, children and adolescents. 1st ed. New York: John Wiley & Sons, 1986: 262–7.
5.
Castro-MaganaMAngeloMFuentesBEffect of prolonged clonidine administration on growth hormone concentrations and rate of linear growth in children with constitutional growth delay. J Pediatr1986; 109: 784–7.
6.
PintorCLocheSCordaRClonidine treatment for short stature. Lancet1987; 1: 1226–30.
7.
LocheSPuggioniRFanniTAugmentation of growth hormone secretion in children with constitutional growth delay by short term clonidine administration: A pulse-amplitude modulated phenomenon. J Clin Endocrinol Metab1989; 68: 426–30.
8.
PescovitzOHTanE. Lack of benefit of clonidine treatment for short stature in a double-blind, placebo-controlled trial. Lancet1988; 2: 874–7.
9.
PintorCLocheSCellaSMullerEE. Clonidine for short stature (letter). Lancet1988; 2: 1191.
10.
Disant'AgneseP. Cystic fibrosis (mucoviscidosis). Am Fam Physician1973; 7: 102–11.
11.
WheelerWBColtenHR. Cystic fibrosis: Current approach to diagnosis and management. Pediatr Rev1988; 9: 241–8.
12.
ChengSHGregoryRJMarshallJDefective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis. Cell1990; 63: 827–34.
13.
NewhouseMTRossmanCMDolovichJDolovichMBWilsonWM. Impairment of mucociliary transport in cystic fibrosis. Mod Probl Pediatr1977; 19: 190–8.
14.
WannerARaoA. Clinical indications for and effects of blind, mucolytic, and antimicrobial aerosols. Am Rev Respir Dis1980; 122: 79–103.
15.
LarsenGLBarronRJLandayRAIntravenous aminophylline in patients with cystic fibrosis. Am J Dis Child1980; 134: 1143–8.
16.
HyamsDE. Amiloride: a review. Royal Society of Medicine, International Congress and Symposium Series 1981; 44: 65–73.
17.
AppEMKingMHelfesriederRKohlerDMatthysH. Acute and long-term amiloride inhalation in cystic fibrosis lung disease. Am Rev Respir Dis1990; 141: 605–12.
18.
KnowlesMGatzyJBoucherR. Increased bioelectric potential difference across respiratory epithelia in cystic fibrosis. N Engl J Med1981; 305: 1489–95.
19.
KnowlesMRChurchNLWaltnerWEA pilot study of aerosolized amiloride for the treatment of lung disease in cystic fibrosis. N Engl J Med1990; 322: 1189–94.
ImmergutMBoldusRYannoneEThe local application of testosterone cream to the prepubertal phallus. J Urol1971; 105: 905–6.
22.
GalimBen EHillmanREWeldonVV. Topically applied testosterone and phallic growth. Its effect in male children with hypopituitism and microphallus. Am J Dis Child1980; 134: 296–8.
23.
JacobsSCKaplanGWGittesRF. Topical testosterone therapy for penile growth. Urology1975; 6: 708–10.
24.
KlugoRCCernyJC. Response of micropenis to topical testosterone and gonadotropin. J Urol1978; 119: 667–8.
DarbyCWVandurschueren-LodoweyckMLauranceBM. Testosterone cream: Use or abuse? (letter)Lancet1974; 2: 598.
27.
FriedrichEGKalraPS. Serum levels of sex hormones in vulvar lichen sclerosis, and the effect of topical testosterone. N Engl J Med1984; 310: 488–91.
28.
ZelleK. Treatment of vulvar dystrophies with topical testosterone propionate. Am J Obstet Gynecol1971; 109: 570–3.
29.
CunninghamGRCorderoEThornbyJI. Testosterone replacement with transdermal therapeutic systems. JAMA1989; 261: 2525–30.
30.
FindlayJCPlaceVSnyderPJ. Treatment of primary hypogonadism in men by the transdermal administration of testosterone. J Clin Endocrinol Metab1989; 68: 369–73.
31.
Bals-PratachMKnuthUAYoonYD. Transdermal testosterone substitution therapy for male hypogonadism. Lancet1986; 2: 943–5.
